Affiliation:
1. 1 Department of Electrical Engineering, Stanford University, Stanford, California 94305, USA
2. 2 Department of Materials Science and Engineering, Stanford University, Stanford, California 94305, USA
Abstract
Breakthroughs within the fields of genomics and bioinformatics have enabled the identification of numerous genetic biomarkers that reflect an individual's disease susceptibility, disease progression, and therapy responsiveness. The personalized medicine paradigm capitalizes on these breakthroughs by utilizing an individual's genetic profile to guide treatment selection, dosing, and preventative care. However, integration of personalized medicine into routine clinical practice has been limited—in part—by a dearth of widely deployable, timely, and cost-effective genetic analysis tools. Fortunately, the last several decades have been characterized by tremendous progress with respect to the development of molecular point-of-care tests (POCTs). Advances in microfluidic technologies, accompanied by improvements and innovations in amplification methods, have opened new doors to health monitoring at the point-of-care. While many of these technologies were developed with rapid infectious disease diagnostics in mind, they are well-suited for deployment as genetic testing platforms for personalized medicine applications. In the coming years, we expect that these innovations in molecular POCT technology will play a critical role in enabling widespread adoption of personalized medicine methods. In this work, we review the current and emerging generations of point-of-care molecular testing platforms and assess their applicability toward accelerating the personalized medicine paradigm.
Funder
Affymetrix Bio-X Stanford Interdisciplinary Graduate Fellowship
Subject
Condensed Matter Physics,General Materials Science,Fluid Flow and Transfer Processes,Colloid and Surface Chemistry,Biomedical Engineering
Reference333 articles.
1. Personalized diagnostics and biosensors: A review of the biology and technology needed for personalized medicine;Crit. Rev. Biotechnol.,2014
2. Translating genomic biomarkers into clinically useful diagnostics;Expert Rev. Mol. Diagn.,2006
3. Genetic variations and precision medicine;Perspect. Health Inf. Manag.,2019
4. Clinical application of pharmacogenomics;J. Pharm. Pract.,2012
5. Individual response to drug therapy: Bases and study approaches;Rev. Invest. Clin.,2012
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献